Michael Platten

Heidelberg University

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (4)

Ghazaleh Tabatabai

Professor

Eberhard Karls Universität Tübingen

GERMANY

View details

Jan-Michael Werner

University of Cologne

GERMANY

View details

Matthias Preusser

Medical University

AUSTRIA

View details

Florien Boele

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Platten

Research Interests

Explore related searches

Contact this professor

Articles (10)

Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions

Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lessons ignored?

Rational engineering of minimally immunogenic nucleases for gene therapy

Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy

Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen

Chairing scientific sessions at international Neuro-Oncology meetings: An EANO guide for early-career professionals

Heating Up IDH-Mutant Gliomas

Bottom-up synthetic immunology

Celebrating the 30th Anniversary of the European Association of Neuro-Oncology

Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 study

Collaborators (4)

Ghazaleh Tabatabai

Jan-Michael Werner

Matthias Preusser

Florien Boele

Make your next move.